The Use of Beta-Blockers for the Treatment of Periocular Hemangiomas in Infants Ophthalmic Technology Assessment

Text Registration

The Use of Beta-Blockers for the Treatment of Periocular Hemangiomas in Infants Ophthalmic Technology Assessment

Status

Published

on 9 Apr 2019

Year of Creation

2018

American Academy of Ophthalmology

Registration Number

TX0008730188

on 9 Apr 2019

The U.S. Copyright record (Registration Number: TX0008730188) dated 9 Apr 2019, pertains to an electronic file (eService) titled "The Use of Beta-Blockers for the Treatment of Periocular Hemangiomas in Infants Ophthalmic Technology Assessment" created in 2018. The copyright holder is American Academy of Ophthalmology, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to American Academy of Ophthalmology.

American Academy of Ophthalmology

Application Details

Registration Number

TX0008730188

Registration Date

4/9/2019

Year of Creation

2018

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

Personal Authors

Corporate Authors

American Academy of Ophthalmology

Notes

Host Item Entry: Ophthalmology vol. 126, no. 1, January 2019, p. 146-155

Statements

Application Title Statement: The Use of Beta-Blockers for the Treatment of Periocular Hemangiomas in Infants Ophthalmic Technology Assessment

Author Statement: Amy K. Hutchinson Domicile: United States Authorship: text Raymond T. Kraker Domicile: United States Authorship: text Stacy L. Pineles Domicile: United States Authorship: text Deborah K. VanderVeen Domicile: United States Authorship: text Lorri B. Wilson Domicile: United States Authorship: text Jennifer A. Galvin Domicile: United States Authorship: text Scott R. Lambert Domicile: United States Authorship: text

Notes

Host Item Entry: Ophthalmology vol. 126, no. 1, January 2019, p. 146-155

Statements

Application Title Statement: The Use of Beta-Blockers for the Treatment of Periocular Hemangiomas in Infants Ophthalmic Technology Assessment

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.